These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2869818

  • 1. Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease.
    Rossor M, Iversen LL.
    Br Med Bull; 1986 Jan; 42(1):70-4. PubMed ID: 2869818
    [No Abstract] [Full Text] [Related]

  • 2. [Alzheimer's disease and neurotransmitters].
    Nakamura S.
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):30-40. PubMed ID: 1672465
    [No Abstract] [Full Text] [Related]

  • 3. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders.
    Mann DM, Yates PO.
    Hum Neurobiol; 1986 Jan; 5(3):147-58. PubMed ID: 2876973
    [Abstract] [Full Text] [Related]

  • 4. Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus.
    Sparks DL, DeKosky ST, Markesbery WR.
    Arch Neurol; 1988 Sep; 45(9):994-9. PubMed ID: 2901257
    [Abstract] [Full Text] [Related]

  • 5. Amnesia and Alzheimer's disease: which neurotransmitter system is responsible?
    Wenk GL.
    Neurobiol Aging; 1988 Sep; 9(5-6):640-1. PubMed ID: 2905431
    [Abstract] [Full Text] [Related]

  • 6. An update on the neurochemistry of Alzheimer disease.
    Davies P.
    Adv Neurol; 1983 Sep; 38():75-86. PubMed ID: 6137134
    [No Abstract] [Full Text] [Related]

  • 7. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P.
    Res Publ Assoc Res Nerv Ment Dis; 1979 Sep; 57():153-66. PubMed ID: 33427
    [No Abstract] [Full Text] [Related]

  • 8. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR, Palmer AM, Bowen DM, Wilcock GK, Esiri MM, Davison AN.
    Neurochem Pathol; 1979 Sep; 2(4):221-32. PubMed ID: 6085697
    [Abstract] [Full Text] [Related]

  • 9. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL, Hunsaker JC, Slevin JT, DeKosky ST, Kryscio RJ, Markesbery WR.
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [Abstract] [Full Text] [Related]

  • 10. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
    Godridge H, Reynolds GP, Czudek C, Calcutt NA, Benton M.
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):775-8. PubMed ID: 2440994
    [Abstract] [Full Text] [Related]

  • 11. Brain monoamines and their metabolites in dementia.
    Gottfries CG.
    Acta Neurol Scand Suppl; 1990 Jun; 129():8-11. PubMed ID: 1977275
    [No Abstract] [Full Text] [Related]

  • 12. Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease.
    Bowen DM, Davison AN.
    Br Med Bull; 1986 Jan; 42(1):75-80. PubMed ID: 2869819
    [No Abstract] [Full Text] [Related]

  • 13. The role of the neurotransmitters in the epilepsies.
    Maynert EW, Marczynski TJ, Browning RA.
    Adv Neurol; 1975 Jan; 13():79-147. PubMed ID: 3107
    [No Abstract] [Full Text] [Related]

  • 14. [Neurochemistry in Alzheimer's disease].
    Hariguchi S.
    Seishin Shinkeigaku Zasshi; 1987 Jan; 89(9):669-79. PubMed ID: 2894694
    [No Abstract] [Full Text] [Related]

  • 15. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG.
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract] [Full Text] [Related]

  • 16. [Neurotransmitters in Alzheimer's disease].
    Manzano-Palomo S, De la Morena-Vicente MA, Barquero MS.
    Rev Neurol; 1985 Feb; 42(6):350-3. PubMed ID: 16575771
    [Abstract] [Full Text] [Related]

  • 17. Nutrients, neurotransmitter synthesis, and the control of food intake.
    Wurtman RJ, Wurtman JJ.
    Res Publ Assoc Res Nerv Ment Dis; 1984 Feb; 62():77-86. PubMed ID: 6141631
    [No Abstract] [Full Text] [Related]

  • 18. Neurotransmitter changes in early- and late-onset Alzheimer-type dementia.
    Arai H, Ichimiya Y, Kosaka K, Moroji T, Iizuka R.
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Feb; 16(6):883-90. PubMed ID: 1381103
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hippocampus pathology in dementia: post-mortem assessed cation shifts and amino acid transmitter contents and its possible neuroimaging in vivo.
    Korf J, Gramsbergen JB.
    Electroencephalogr Clin Neurophysiol Suppl; 1991 Feb; 42():366-79. PubMed ID: 1680671
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.